Evidence map›Paper›PMID 40221844›Full record

ReviewMedicinal research reviews2025

The Quinoline Photoremovable Group (PPG) Platform-A Medicinal Chemist's Approach for Photocage Development and Applications.

Bence Kontra, Zoltán Mucsi, Janez Ilaš, Petra Dunkel

Abstract readReview
In one paragraph

Review in Medicinal research reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bence KontraInstitute of Organic Chemistry, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-8293-3637
Zoltán MucsiDepartment of Biological Chemistry, BrainVision Center, Budapest, Hungary.ORCID 0000-0003-3224-8847
Janez IlašFaculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.ORCID 0000-0002-0124-0474
Petra DunkelInstitute of Organic Chemistry, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-5445-8357

Funding

This study was supported by grants from the National Research, Development and Innovation Office (NKFIH) (Grant Numbers: SNN 135825, TKP2021-NVA-14, and ED-2022-00208); Slovenian Research and Innovation Agency (ARIS) Project P1-0208.
6 · The paper itself

Abstract

Photoremovable protecting groups (PPGs) offer a straightforward solution for the temporary inactivation of biologically active substrates and their subsequent controlled release by light irradiation. Their relatively easy design and mode of application have made them useful tools for studying dynamic biological processes in vitro and in vivo. Recently, there has been a growing body of data investigating their potential application in the development of drug delivery systems. Of the various PPG scaffolds in use, quinoline photocages have a history of about 20 years. The structure-property relationships of quinoline PPGs, as well as alternative multibranch designs based on quinoline monomers have been thoroughly studied both experimentally and theoretically. Therefore, quinoline PPGs serve as a representative study of PPG development, showing how the various applications of quinoline photocages followed the chemical optimization or how the applications drove the chemical design. Since the raison d'être of PPGs lies in their application for light-activated release of various substrates or performing light-activated structural changes in materials, it is crucial to understand how PPGs are selected and utilized by their end-users, who are often not chemists themselves. Therefore, we discuss whether the conclusions drawn from the selected quinoline PPG family could lead to more general insights for the field as whole. As PPG-related applications still rely heavily on a limited number of chemical scaffolds, it is worth considering, what could be the reasons for the slow uptake of novel chemical scaffolds.

Indexed as

QuinolinesChemistry, PharmaceuticalDrug Delivery SystemsHumansLightquinolineQuinolinesdrug delivery systemsneuronal signalingphotoremovable protecting groupsquinoline photocagesstructure‐property relationshipstwo‐photon absorptiontwo‐photon uncaging

Identifiers

PMID40221844
PMCPMC12322520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.